Hangzhou, China · Founded 2017 · In IPO Registration
Developer of a drug development approach designed to create therapies for autoimmune and inflammatory diseases affecting systemic and central nervous system conditions. Highlightll Pharma is based in Hangzhou, China and was founded in 2017. Its last reported valuation was $346 million in Nov 2025. It has raised $97.3 million.
Last reported valuation
$346.2M
Oct 2026
Priced at
—
Total raised
$97.3M
Last round
—
Team — not yet on record
No current team members for Highlightll Pharma are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Highlightll Pharma with a free account
·The complete investor list: 11 names
·Watch Highlightll Pharma: the Monday email on marks, rounds and moves
